Pritchett YL

References (2)

Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD
Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015
Abstract :
PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
PubMedID: 25973909

Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715
Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD
Ref : Psychopharmacology (Berl) , 219 :715 , 2012
Abstract :
PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715
PubMedID: 21748252